Alternative interventional multimodality therapies for the management of liver malignancies

Journal of B.U.ON.

Volumn 10, Issue 1, 2005, Pages 23-33

  Filippou, Dimitrios K ^a,c   Avgerinos, E D ^b   Pavlakis, E ^b   Rizos, S ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Liver ablation; Liver metastases

Indexed keywords

ALCOHOL; ANTIPYRETIC AGENT; CISPLATIN; HYDROCORTISONE;

ABDOMINAL PAIN; ARTIFICIAL EMBOLISM; CANCER MORTALITY; CRYOTHERAPY; FEVER; HUMAN; INJECTION; LASER COAGULATION; LIVER CANCER; LIVER RESECTION; LIVER SURGERY; MICROWAVE THERAPY; MORBIDITY; MULTIMODALITY CANCER THERAPY; NAUSEA; OUTCOMES RESEARCH; PATIENT SELECTION; RADIOFREQUENCY RADIATION; REVIEW; TREATMENT INDICATION; ULTRASOUND TRANSDUCER; YAG LASER;

EID: 24944478992     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Okuda K, Kojiro M, Okuda H. Neoplasms of the liver. In: Schiff L, Schiff ER (eds): Diseases of the liver (7th edn). JB Lippincott Co, Phildelphia, 1993, pp 1236-1226.
2. Rustgi VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 1987; 16: 545-551.
3. Lau WY. Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y (eds): Surgery of the liver and biliary tract (3rd edn). WB Saunders, Philadelphia, New York, London, Sidney, St. Louis, Toronto, 2000, pp 1423-1450.
4. Vilana R, Bruix J, Bru C et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992; 16: 354-357.
5. Colleoni M, Audisio RA, De Braud F et al. Practical considerations in the treatment of hepatocellular carcinoma. Drugs 1998; 55: 367-382.
6. Yamada K, Sato M, Kawabata M et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401.
7. Ueno K, Miyazono N, Inoue H et al. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000; 88: 1574-1581.
8. Kawai S, Tani M, Okamura J et al. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol 1997; 24 (2 Suppl 6): S38-S45.
9. Ikeda K, Saitoh S, Suzuki Y et al. A prospective randomized administration of 5′-deoxy-5-fluorouridine as adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Am J Clin Oncol 1997; 20: 202-208.
10. Nishimine K, Uchida H, Matsuo N et al. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 1994; 33(Suppl): S60-S68.
11. Llovet JM, Sala M, Bruix J. Nonsurgical treatment of hepatocellular carcinoma. Liver Transpl 2000; 6(6 Suppl 2): S11-S15.
12. Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 1988; 15: 1-31.
13. Bismuth H, Morino M, Sherlock D et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163: 387-394.
14. Caturelli E, Siena DA, Fusilli S et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 2000; 215: 123-128.
15. Matsui O, Kadoja M, Yoshikawa J et al. Small hepatocellular carcinoma: treatment with subsegmental arterial embolization. Radiology 1993; 188: 78-93.
16. Uchida H, Matsuo N, Nishimine K et al. Transcatheter arterial embolization for hepatoma with lipiodol. Hepatic arterial and segmental use. Semin Intervent Radiol 1993; 10: 19-26.
17. Cammà C, Filippo S, Ambrogio O et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-Analysis of randomized controlled trials. Radiology 2002; 224: 47-54.
18. Leichman CG, Jacobson JR, Modiano M et al. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma. A southwest Oncology Group pilot trial. Cancer 1999; 86: 775-781.
19. Kokudo N, Makuuchi M. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 2004; 84: 643-657.
20. Venook AP, Stagg RJ, Lewis BJ et al. Chemoembolization for hepatocellular carcinoma. J Clin Oncol 1990; 8: 1108-1114.
21. Ernst O, Sergent G, Mizrahi D et al. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. Am J Roentgenol 1999; 172: 59-64.
22. Berger DH, Carrasco CH, Hohn DC et al. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J Surg Oncol 1995; 60: 116-121.
23. De Baere T, Roche A, Amenabar JM et al. Liver abscess formation after local treatment of liver tumors. Hepatology 1996; 23: 1436-1440.
24. Kim W, Clark TW, Baum RA et al. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001; 12: 965-968.
25. Song SY, Chung JW, Han JK et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001; 12: 313-320.
26. Sugiura N, Takara K, Ohto M et al. Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real-time ultrasound monitoring. Acta Hepatol Japan 1983; 24: 920.
27. Brown KT, Brody LA. Percutaneous methods for ablation of hepatic neoplasms. In: Blumgart LH, Fong Y (eds): Surgery of the liver and biliary tract (3rd edn). WB Saunders, Philadelphia, New York, London, Sidney, St. Louis, Toronto, 2000, pp 1565-1576.
28. Bartolozzi C, Lencioni R. Ethanol injection for the treatment of hepatic tumors. Eur Radiol 1996; 6: 682-696.
29. Lencioni R, Pinto F, Armillotta N et al. Long term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997; 7: 514-519.
30. Livraghi T, Bolondi L, Lazzaroni S et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925-929.
31. Meloni F, Lazzaroni S, Livraghi T. Percutaneous ethanol injection: single session treatment. Eur J Ultrasound 2001; 13: 107-115.
32. Livraghi T, Vettori C, Torzilli G et al. Percutaneous ethanol injection of hepatic tumors: Single session therapy under general anesthesia. Am J Radiol 1993; 161: 1065-1069.
33. Livraghi T. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Hepatogastroenterology 2001; 48: 20-24.
34. Livraghi T, Giorgio A, Marin G et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-108.
35. Shiina S, Tagawa K, Niwa Y et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 160: 1023-1028.
36. Castells A, Bruix J, Bru C et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18: 1121-1126.
37. Yamamoto J, Okada S, Shimada K et al. Treatment strategy for small hepatocellular carcinoma: comparison of long term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-713.
38. Ryu M, Shimamura Y, Kinoshita T et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997; 27: 251-257.
39. Arii S, Yamaoka Y, Futagawa S et al. Results of surgical and nonsurgical treatment for small - sized hepatocellular carcinomas. A retrospective and nationwide survey in Japan. Hepatology 2000; 32: 1224-1229.
40. Amin Z, Bown SG, Lees WR. Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol 1993; 48: 166-171.
41. Livraghi T, Vettori C, Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology 1991; 179: 709-712.
42. Llovet J, Vilana R, Bru C et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-1129.
43. Kato T, Reddy KR. Radiofrequency ablation for hepatocellular carcinoma: help hazard? Hepatology 2001; 33: 1336-1337.
44. Giovannini M, Seitz JF. Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer 1994; 73: 294-297.
45. Di Stasi M, Buscarini L, Livraghi T et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997; 32: 1168-1173.
46. Hou C, Chen SC, Chang WY et al. Comparison of necrotic characteristics and benefits between 50% acetic acid and pure ethanol in local hepatic injection: a study in rats. Kaohsiung J Med Sci 1999; 15: 414-418.
47. Tamai T, Seki T, Imamura M et al. Percutaneous injection of a low-concentration alkaline solution targeting hepatocellular carcinoma. Oncol Rep 2000; 7: 719-723
48. Honda N, Guo Q, Uchida H et al. Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. Radiology 1994; 190: 53-57.
49. Rossi S, Garbagnati F, Lencioni R et al. Percutaneous radio-frequency thermal ablation of non-resectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217: 119-126.
50. Rossi S, Buscarini E, Garbagnati F et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 1998; 170: 1015-1022.
51. Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8.
52. Chamberlain R, Fong Y. Radiofrequency thermal ablation of liver tumors. In: Blumgart LH, Fong Y (eds): Surgery of the liver and biliary tract (3rd edn). WB Saunders, Philadelphia, New York, London, Sidney, St. Louis, Toronto, 2000, pp 1588-1595.
53. Cushieri A, Bracken J, Boni L. Initial experience with laparoscopic ultrasound-guided radiofrequency thermal ablation of hepatic tumors. Endoscopy 1994; 31: 318-321.
54. Hiotis S, Brown K. Nonsurgical ablative techniques for liver tumors. In: Blumgart LH, Fong Y, Jarnagin W (eds): Hepatobiliary cancer. BC Decker, New York, 2001, pp 145-158.
55. Kaleya R, Kishinevsky A, Ravikumar T. Surgical ablative therapy for liver tumors. In: Blumgart LH, Fong Y, Jarnagin W (eds): Hepatobiliary cancer. BC Decker, New York, 2001, pp 117-144.
56. Solbiati L, Ierace T, Tonolini M et al. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001; 13: 149-158.
57. Goldberg SN, Gazelle GS, Halpern EF et al. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3: 212-218.
58. Rossi S, Di Stasi M, Buscarini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996; 167: 759-768.
59. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guided radio-frequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 1993; 8: 97-103.
60. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound 2001; 13: 159-166.
61. Solbiati L, Livraghi T, Goldberg SN et al. Percutaneous radiofrequency ablation of hepatic metastases colorectal cancer: long-term results in 117 patients. Radiology 2001; 221: 159-166.
62. Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for the treatment of neuroendocrine liver metastases. World J Surg 2001; 25: 693-696.
63. Livraghi T, Goldberg SN, Solbiati L et al. Percutaneous radiofrequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001; 220: 145-149.
64. Zagoria RJ, Chen MY, Shen P, Levine EA. Complications from radiofrequency ablation of liver metastases. Am Surg 2002; 68: 204-209.
65. Gage AA, Baust J. Mechanism of tissue injury in cryosurgery. Cryobiology 1998; 37: 171-186.
66. Ravikumar TS, Steele GD Jr. Hepatic cryosurgery. Surg Clin North Am 1989; 69: 433-440.
67. Rubinsky B, Lee CY, Bastacky J et al. The process of freezing and the mechanism of damage during hepatic cryosurgery. Cryobiology 1990; 27: 85-97.
68. Poston G. Cryosurgery for colorectal liver metastases. Hepatogastroenterology 2001; 48: 323-324.
69. Ravikumar TJ, Kane R, Cady B et al. Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch Surg 1987; 122: 403-409.
70. Zhou XD. Tang ZY, Yu YQ et al. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer 1998; 61: 1889-1892.
71. Cady B, Stone MD, McDermott WV Jr et al. Technical and biological factors in disease free survival after hepatic resection for colorectal metastases. Arch Surg 1992; 127: 561-569.
72. Steele G. Cryoablation in hepatic surgery. Semin Liver Dis 1994; 14: 120-125.
73. Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg 2002; 89: 1396-1401.
74. Shimonov M, Shechter P, Victoria F et al. Laparoscopic cryoablation of liver tumors. Harefuah 2002; 141: 414-417.
75. Chung MH, Ye W, Ramming KP et al. Repeat hepatic cryotherapy for metastatic colorectal cancer. J Gastrointest Surg 2001; 5: 287-293.
76. Seifert JK, Achenbach T, Heintz A et al. Cryotherapy for liver metastases. Int J Colorectal Dis 2000; 15: 161-166.
77. Weaver ML, Ashton JG, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998; 14: 163-170.
78. Hewitt PM, Dwerryhouse SJ, Zhao J et al. Multiple bilobar liver metastases: cryotherapy for residual lesions after liver resection. J Surg Oncol 1998; 67: 112-116.
79. Seifert JK, Heintz A, Junginger T. Cryotherapy for primary and secondary liver tumours. Zentralbl Chir 2002; 127: 275-281.
80. Adam R, Akrinar E, Johann M et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997; 225: 39-50.
81. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228: 201-208.
82. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995; 76: 210-214.
83. Tabuse K. A new operative procedure for hepatic surgery using a microwave tissue coagulator. Arch Jpn Chir 1979; 48: 160-172.
84. Seki T, Wakabayashi M, Nakagawa T et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817-825.
85. Tabuse K, Katsumi M. Application of a microwave tissue coagulator to hepatic surgery; the hemostatic effects on spontaneous rupture of hepatoma and tumor necrosis. Nippon Geka Hokan 1981; 50: 571-579.
86. Hamazoe R, Hirooka Y, Ohtani S et al. Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma. Cancer 1995; 75: 794-799.
87. Watanabe Y, Sato M, Abe Y et al. Laparoscopic microwave coagulo-necrotic therapy for hepatocellular carcinoma: a feasible study of an alternative option for poor-risk patients. J Laparoendosc Surg 1995; 5: 169-175.
88. Seki T, Wakabayashi M, Nakagawa T et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma. Cancer 1999; 85: 1694-1701.
89. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000; 89: 276-284.
90. Takamura M, Murakami T, Shibata T et al. Microwave coagulation therapy with interruption of hepatic blood in-or out- flow: an experimental study. J Vasc Interv Radiol 2001; 12: 619-622.
91. Ishida T, Murakami T, Shibata T et al. Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow. J Vasc Interv Radiol 2002; 13: 185-191.
92. Shibata T, Murakami T, Ogata N. Percutaneous microwave coagulation therapy for patients with primary and metastatic hepatic tumors during interruption of hepatic blood flow. Cancer 2000; 88: 302-311.
93. Itamoto T, Asahara T, Kohashi T et al. Percutaneous microwave coagulation therapy for hepatocellular carcinoma. Gan To Kagaku Ryoho 1999; 26: 1841-1844.
94. Lu MD, Chen JW, Xie XY et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221: 167-172.
95. Beppu T, Doi K, Ishiko T et al. Efficacy of local ablation therapy for liver metastasis from colorectal cancer - radiofrequency ablation and microwave coagulation therapy. Nippon Geka Gakkai Zasshi 2001; 102: 390-397.
96. Seki S, Sakaguchi H, Kadoya H et al. Laparoscopic microwave coagulation therapy for hepatocellular carcinoma. Endoscopy 2000; 32: 591-597.
97. Seki T, Tamai T, Nakagawa T et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245-1251.
98. Horigone H, Nomura T, Saso K et al. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: Consideration of local recurrence. Am J Gastroenterol 1999; 94: 1914-1917.
99. Shimada S, Hirota M, Beppu T et al. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg Today 1998; 28: 1130-1137.
100. Heisterkamp J, van Hillegersberg R, Mulder PG et al. Importance of eliminating portal flow to produce large intrahepatic lesions with interstitial laser coagulation. Br J Surg 1997; 84: 1245-1248.
101. Amin Z, Donald JJ, Masters A et al. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology 1993; 187: 339-347.
102. Nolsoc CP, Torp-Pedersen S, Burcharth F et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: A pilot clinical study. Radiology 1993; 187: 333-337.
103. Vogl T, Muller PK, Harrestingl R et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: Technique and prospective results. Radiology 1995; 196: 257-265.
104. Pacella CM, Bizzarri G, Cecconi P et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219: 669-678.
105. Vogi TJ, Mack MG, Straub R et al. Percutaneous MRI-guided laser-induced thermotherapy for hepatic metastases for colorectal cancer. Lancet 1997; 350: 29.
106. Pacella CM, Bizzarri G, Magnolfi F et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology 2001; 221: 712-720.